Provided by Tiger Trade Technology Pte. Ltd.

AIM VACCINE

1.580
-0.025-1.56%
Volume:130.20K
Turnover:210.38K
Market Cap:1.94B
PE:-2.87
High:1.690
Open:1.560
Low:1.560
Close:1.605
52wk High:5.650
52wk Low:1.200
Shares:1.23B
HK Float Shares:507.67M
Volume Ratio:0.19
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.550
ROE:-22.72%
ROA:-1.87%
PB:0.60
PE(LYR):-2.87
PS:1.42

Loading ...

AIM VACCINE (06660) Files for Market Approval of Next-Generation High-Potency Human Diploid Cell Rabies Vaccine, Showcasing Superior Technology

Stock News
·
Aug 24

AIM Vaccine Files NMPA Registration for High-Potency Human Diploid Rabies Vaccine

Reuters
·
Aug 24

AIM Vaccine Co - Submits Application for High-Potency Human Diploid Cell Rabies Vaccine in China

THOMSON REUTERS
·
Aug 24

Moderna's Breakthrough Ignites mRNA Cancer Vaccine Rally, Undervalued Sector Leaders Poised for Revaluation

Stock News
·
Aug 24

AIM VACCINE Posts Interim Results with Revenue of RMB351 Million and Outlines Global Expansion Strategy

Stock News
·
Aug 23

HK Movers | Pharma Stocks Surge With 3D Medicines up 68%, CanSino Biologics up 52%

Tiger Newspress
·
Aug 20

mRNA Cancer Treatment Breakthrough Sparks Historic Rally and Reshapes Industry Valuations

Stock News
·
Aug 20

AIM Vaccine Plans Private Placement of up to 80.00 million Domestic Shares at RMB1.07 Each; Tibet Bohai to Invest RMB40.00 million

Bulletin Express
·
Aug 18

AIM Vaccine Announces Extraordinary General Meeting

Reuters
·
Aug 18

AIM Vaccine Co - Tibet Bohai to Subscribe 37.4 Mln Shares at Rmb1.07 Each

THOMSON REUTERS
·
Aug 18

AIM Vaccine Prices Domestic Unlisted Share Private Placement at RMB 1.07 Per Share

Reuters
·
Aug 18

AIM Vaccine Schedules 23 August 2026 Board Meeting to Approve 1H 2026 Interim Results and Potential Dividend

Bulletin Express
·
Aug 12

AIM Vaccine: July 2026 Share Capital Stable at RMB 1.23 Billion; Public Float Remains Compliant

Bulletin Express
·
Aug 04

AIM Vaccine’s Subsidiary Completes Supplementary Filing for Serum-Free Rabies Shot, Advancing NMPA Registration

Bulletin Express
·
Aug 03

Serum-Free Era Arrives for Rabies Vaccines as AIM VACCINE (06660) Submits Supplemental Data for Its Next-Generation Serum-Free Rabies Vaccine

Stock News
·
Aug 03

AIM Vaccine Submits Additional NMPA Data for Serum-free Rabies Vaccine After Phase III Trial Unblinding

Reuters
·
Aug 03

Puhua Capital-backed Ruivi Technology Lists in Hong Kong, Shares Trade as 07656.hk

Reuters
·
Jul 08

AIM VACCINE Shares Surge Over 8% Intraday Following Board Reshuffle and Accelerated Dual-Listing Strategy

Stock News
·
Jun 24

AIM VACCINE Announces Appointment of Wu Jinian as Executive President

Stock News
·
Jun 10

AIM Vaccine shareholders approve bylaw amendments effective upon NEEQ listing

Reuters
·
Jun 10